Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a53bd912c5951be39d423cf1f6a775fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4664c2234c8f98ef257926850618bdd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c539db959cc0106cab1662303f94fce |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
filingDate |
2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acb79ac96d6379567393e262a275125a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5611fd14a6c3d6688a631756ccc64286 |
publicationDate |
2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006070004-A1 |
titleOfInvention |
Compounds useful in the treatment of hiv |
abstract |
There is provided inter alia use of 2',3'-dideoxy-3'-hydroxymethylcytosine or a prodrug or salt thereof in the manufacture of a medicament for the treatment of HIV infection wherein the reverse transcriptase of the HIV bears at least one mutation that allows an obligate chain terminating nucleoside- or nucleotide phosphate to be excised from the nascent DNA strand by ATP- or pyrophosphate-mediated excision. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8143396-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007006707-A1 |
priorityDate |
2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |